Ocean Biomedical, Inc. Stock Nasdaq
Equities
OCEA
US67644P1057
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 48.51M 66.29M |
---|---|---|---|---|---|
Net income 2023 * | -92M -126M | Net income 2024 * | -32M -43.73M | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.45
x | P/E ratio 2024 * |
-1.57
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 28.01% |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.70% | 23.07B | |
-12.60% | 22.23B | |
-5.24% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |